Facilities

Articles

Confronting pharma's hidden issue: equipment recapitalization

A new benchmarking report reveals powerful opportunities for engineers to streamline manufacturing by rethinking equipment replacement strategies

Effective OEM orchestration is music to pharma’s ears

Adopting a holistic plan early in facility design can help harmonize equipment

The smart factory future is now

For pharma, digitalization on the plant floor has become a hard-fought reality

Technology trends in pharma facility design and engineering

How new technology is helping pharma companies to reduce costs, fully optimize resources and streamline operations

Meeting new sustainability targets

Sustainability in pharma is complex, but there are opportunities for drugmakers and building developers to meet green goals

News

BioNTech to ship modular mRNA factories to Africa

GAO to FDA: Address foreign inspection backlog

FDA pauses facility inspections due to omicron variant

GSK to depart long-held North Carolina campus

Pfizer to mandate vaccines for U.S. workers

Report: Manufacturing contamination caused failed Olympic drug test

Machine condition monitoring in pharma

Strengthening production through asset management

Meeting biopharma’s infrastructure demands

Biopharma facilities must address the specific needs and concerns of this dynamic sector

Pharma facility commissioning in a virtual world

Digital twins can reduce commissioning time by 40%

Engineering angles: Embracing BIM in pharma plant design

It’s time for the industry to overcome hesitations and utilize 3D technology

Beating the space crunch

The pharma industry is running out of lab and manufacturing space — but there are options

A practical approach to DX in ATMPs

How advanced therapy manufacturers can apply DX across facilities

Five tips for reducing downtime at your plant

How can pharma manufacturers strike the right balance between planned and unplanned downtime?

Powering progress in cell therapy

Getting transformative treatments to market will require rethinking processes and facilities

The price of delaying predictive maintenance in pharma

When it comes to maintenance programs, how can the risk-averse industry overcome its outdated cautiousness?

The capital you need may be under your feet

Sale leasebacks can be a strategic tool for the pharma industry